Literature DB >> 25713979

Dynamics of Increasing IFN-γ Exposure on Murine MH-S Cell-Line Alveolar Macrophage Phagocytosis of Streptococcus pneumoniae.

Michael J Mina1,2,3, Lou Ann S Brown3, Keith P Klugman2.   

Abstract

Previous investigations have demonstrated that activation with the type II interferon, IFN-γ, downregulates alveolar macrophage (AM) phagocytosis of Streptococcus pneumoniae. While these studies have shown clear effects at discrete time points, the kinetics of the macrophage response to IFN-γ over time, with respect to pneumococcal phagocytosis, have not been shown. Here, we describe these kinetics in the murine MH-S AM cell-line, a well-established model useful for investigations of AM phenotype and function. We measure binding and internalizing rates of S. pneumoniae following exposure to increasing durations of physiologic levels of IFN-γ. When MH-S murine alveolar macrophage (mAM) were exposed to IFN-γ for increasing durations of time, from 0 to 6 days before inoculation with the type II S. pneumoniae, D39, exposure for 6 h transiently reduced bacterial binding by 50%, which was temporarily restored at 2 and 3 days of exposure. Bacterial internalization was also reduced shortly following initial exposure, however, internalization continued to fall to less than 5% that of IFN-γ naïve controls after 6 days of exposure. These data may help explain otherwise contradictory reports from the literature regarding timing between infections and reductions in macrophage function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25713979      PMCID: PMC4692125          DOI: 10.1089/jir.2014.0087

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  21 in total

1.  Direct stimulation of macrophages by IL-12 and IL-18 - a bridge built on solid ground.

Authors:  M Munder; M Mallo; K Eichmann; M Modolell
Journal:  Immunol Lett       Date:  2001-01-01       Impact factor: 3.685

Review 2.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

3.  MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  J Leukoc Biol       Date:  1989-08       Impact factor: 4.962

4.  Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.

Authors:  S B Gordon; G R Irving; R A Lawson; M E Lee; R C Read
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 5.  The macrophage receptor MARCO.

Authors:  G Kraal; L J van der Laan; O Elomaa; K Tryggvason
Journal:  Microbes Infect       Date:  2000-03       Impact factor: 2.700

6.  Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes.

Authors:  D M Mosser; E Handman
Journal:  J Leukoc Biol       Date:  1992-10       Impact factor: 4.962

7.  Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein.

Authors:  Concepción Nieto; Manuel Espinosa
Journal:  Plasmid       Date:  2003-05       Impact factor: 3.466

8.  Elimination of extracellular bacteria by antibiotics in quantitative assays of bacterial ingestion and killing by phagocytes.

Authors:  S N Tabrizi; R M Robins-Browne
Journal:  J Immunol Methods       Date:  1993-02-03       Impact factor: 2.303

Review 9.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

10.  The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.

Authors:  Mohamed Arredouani; Zhiping Yang; YaoYu Ning; Guozhong Qin; Raija Soininen; Karl Tryggvason; Lester Kobzik
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

View more
  5 in total

1.  Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication.

Authors:  Todd A Brenner; Tyler A Rice; Erik D Anderson; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2016-02-23       Impact factor: 3.685

2.  Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens.

Authors:  Elena Mitsi; Beatriz Carniel; Jesús Reiné; Jamie Rylance; Seher Zaidi; Alessandra Soares-Schanoski; Victoria Connor; Andrea M Collins; Andreas Schlitzer; Elissavet Nikolaou; Carla Solórzano; Sherin Pojar; Helen Hill; Angela D Hyder-Wright; Kondwani C Jambo; Marco R Oggioni; Megan De Ste Croix; Stephen B Gordon; Simon P Jochems; Daniela M Ferreira
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

3.  Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae.

Authors:  Angeline E Rodriguez; Christopher Bogart; Christopher M Gilbert; Jonathan A McCullers; Amber M Smith; Thirumala-Devi Kanneganti; Christopher R Lupfer
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 4.  The Role of Innate Immunity in Pulmonary Infections.

Authors:  Huihui Zhang; Fang He; Pan Li; Philip R Hardwidge; Nengzhang Li; Yuanyi Peng
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

5.  Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza.

Authors:  Amber M Smith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-27       Impact factor: 2.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.